Skip to main content

Abstract

Mitochondria are key organelles providing energy supply and many other vital functions to cells. Shortly after the discovery of plant-derived cannabinoid compounds, some studies indicated their impact onto mitochondrial functions. The later identification of cannabinoid receptors as classical seven-transmembrane G protein-coupled receptors suggested that these mitochondrial effects might be due to unspecific membrane-altering properties of cannabinoids. However, the recent discovery that brain mitochondria contain significant amounts of functional type-1 cannabinoid receptors (CB1) shed new light on cannabinoid physiology and pharmacology. In this chapter, we will summarize historical and recent evidence of the cannabinoid impact on mitochondrial functions in peripheral and central organs of the body.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

Download references

Acknowledgments

The work in Marsicano’s lab is supported by INSERM, EU–Fp7 (REPROBESITY, HEALTH–F2–2008–223713 and PAINCAGE, HEALTH-603191), European Research Council (Endofood, ERC–2010–StG–260515, and CannaPreg, ERC-2014-PoC-640923), Fondation pour la Recherche Medicale (DRM20101220445, DPP20151033974), Human Frontiers Science Program, Region Aquitaine, and Agence Nationale de la Recherche (ANR Blanc NeuroNutriSens ANR-13-BSV4-0006 and BRAIN ANR-10-LABX-0043). We thank all the members of Marsicano’s lab for the useful discussions. The work of Etienne Hebert-Chatelain is supported by the Natural Sciences and Engineering Research Council of Canada (Discovery grant: RGPIN-2015-05880), Alzheimer Society of Canada (New Investigator Award: 17-09), the Canadian Breast Cancer Foundation (Research grant 16880-2015-17342), Beatrice Hunter Cancer Research Institute (Seed Fund), New Brunswick Health Research Foundation, New Brunswick Innovation Foundation, and Université de Moncton.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Etienne Hebert-Chatelain .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Hebert-Chatelain, E., Marsicano, G., Desprez, T. (2017). Cannabinoids and Mitochondria. In: Melis, M. (eds) Endocannabinoids and Lipid Mediators in Brain Functions. Springer, Cham. https://doi.org/10.1007/978-3-319-57371-7_8

Download citation

Publish with us

Policies and ethics